Skip to content

ENDOCYTE INC: 10-K filed 2015-03-13

What ENDOCYTE INC reported in its annual report filed 2015-03-13 (fiscal FY 2014): 37 published measures, 163 facts as tagged in accession 0001144204-15-015921.

This filing

Form
10-K (annual report)
Filed
2015-03-13
Fiscal period
fiscal FY 2014
Accession
0001144204-15-015921 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENDOCYTE INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-31212,801,374USD
At 2013-12-31162,857,576USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-317,797,256USD
At 2013-12-3174,628,855USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-31205,004,118USD
At 2013-12-3188,228,721USD
At 2012-12-3199,573,278USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-3145,533,443USD
At 2013-12-3152,846,940USD
At 2012-12-3133,996,866USD
At 2011-12-3161,352,483USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-8,081USD92
2014-01-01 to 2014-12-315,459,477USD365
2014-07-01 to 2014-09-30-5,675USD92
2014-04-01 to 2014-06-3022,356USD91
2014-01-01 to 2014-03-31-3,141USD90
2013-10-01 to 2013-12-31-2,902USD92
2013-01-01 to 2013-12-31-18,032,438USD365
2013-07-01 to 2013-09-30-3,041USD92
2013-04-01 to 2013-06-30-8,227USD91
2013-01-01 to 2013-03-31-3,862USD90
2012-01-01 to 2012-12-31-17,291,758USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,501,744USD365
2013-01-01 to 2013-12-31827,839USD365
2012-01-01 to 2012-12-311,862,872USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-10-01 to 2014-12-3112USD92
2014-01-01 to 2014-12-3170,353,483USD365
2014-07-01 to 2014-09-303,904USD92
2014-04-01 to 2014-06-3049,168USD91
2014-01-01 to 2014-03-3117,269USD90
2013-10-01 to 2013-12-3117,274USD92
2013-01-01 to 2013-12-3164,870,919USD365
2013-07-01 to 2013-09-3016,600USD92
2013-04-01 to 2013-06-3016,483USD91
2013-01-01 to 2013-03-3114,514USD90
2012-01-01 to 2012-12-3134,682,111USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31-168,465,239USD
At 2013-12-31-173,924,716USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-10-01 to 2014-12-3141,736,930shares92
2014-01-01 to 2014-12-3140,242,352shares365
2014-07-01 to 2014-09-3041,564,840shares92
2014-04-01 to 2014-06-3041,398,251shares91
2014-01-01 to 2014-03-3136,193,942shares90
2013-01-01 to 2013-12-3136,036,996shares365
2012-01-01 to 2012-12-3135,858,757shares366

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-10-01 to 2014-12-3141,736,930shares92
2014-01-01 to 2014-12-3141,758,101shares365
2014-07-01 to 2014-09-3041,564,840shares92
2014-04-01 to 2014-06-3043,196,754shares91
2014-01-01 to 2014-03-3136,193,942shares90
2013-01-01 to 2013-12-3136,036,996shares365
2012-01-01 to 2012-12-3135,858,757shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-0.19USD/shares92
2014-01-01 to 2014-12-310.14USD/shares365
2014-07-01 to 2014-09-30-0.14USD/shares92
2014-04-01 to 2014-06-300.54USD/shares91
2014-01-01 to 2014-03-31-0.09USD/shares90
2013-01-01 to 2013-12-31-0.5USD/shares365
2012-01-01 to 2012-12-31-0.48USD/shares366

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-0.19USD/shares92
2014-01-01 to 2014-12-310.13USD/shares365
2014-07-01 to 2014-09-30-0.14USD/shares92
2014-04-01 to 2014-06-300.52USD/shares91
2014-01-01 to 2014-03-31-0.09USD/shares90
2013-01-01 to 2013-12-31-0.5USD/shares365
2012-01-01 to 2012-12-31-0.48USD/shares366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-313,970,665USD
At 2013-12-313,839,426USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-12-318,025,261USD365
2013-01-01 to 2013-12-316,059,005USD365
2012-01-01 to 2012-12-313,022,693USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-8,187USD92
2014-01-01 to 2014-12-315,026,728USD365
2014-07-01 to 2014-09-30-5,778USD92
2014-04-01 to 2014-06-3022,210USD91
2014-01-01 to 2014-03-31-3,219USD90
2013-10-01 to 2013-12-31-2,963USD92
2013-01-01 to 2013-12-31-18,341,783USD365
2013-07-01 to 2013-09-30-3,044USD92
2013-04-01 to 2013-06-30-8,335USD91
2013-01-01 to 2013-03-31-4,001USD90
2012-01-01 to 2012-12-31-16,042,676USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-31127,038,338USD
At 2013-12-31133,331,530USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,189USD365
2013-01-01 to 2013-12-312,458USD365
2012-01-01 to 2012-12-31628,993USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-316,884,996USD
At 2013-12-3173,663,457USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-12-311,234,759USD
At 2013-12-315,435,473USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2014-01-01 to 2014-12-313,814USD365
2013-01-01 to 2013-12-310USD365
2012-01-01 to 2012-12-310USD366

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-12-3165,326,755USD365
2013-01-01 to 2013-12-3183,212,702USD365
2012-01-01 to 2012-12-3150,724,787USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-10-01 to 2014-12-313,998USD92
2014-01-01 to 2014-12-3141,649,389USD365
2014-07-01 to 2014-09-305,675USD92
2014-07-01 to 2014-07-312,200,000USD31
2014-04-01 to 2014-06-3018,990USD91
2014-01-01 to 2014-03-3112,987USD90
2013-10-01 to 2013-12-3113,533USD92
2013-01-01 to 2013-12-3157,898,971USD365
2013-07-01 to 2013-09-3013,501USD92
2013-04-01 to 2013-06-3018,607USD91
2013-01-01 to 2013-03-3112,259USD90
2012-01-01 to 2012-12-3135,670,418USD366
2011-02-01 to 2011-02-28300,000USD28

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-12-3141,784,692shares
At 2013-12-3136,155,509shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-12-31-143,928USD
At 2013-12-3156,691USD
At 2012-12-3172,749USD
At 2011-12-31-6,264USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-12-317,477,197USD
At 2013-12-316,621,291USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-12-313,506,532USD
At 2013-12-312,781,865USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-3131,194USD
At 2013-12-31114,961USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-3130,316USD
At 2013-12-3133,458USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-12-31692,526USD
At 2013-12-311,668,944USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2014-12-310USD
At 2013-12-310USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-12-315,258,858USD365
2013-01-01 to 2013-12-31-18,048,496USD365
2012-01-01 to 2012-12-31-17,212,745USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-10-01 to 2014-12-314,201USD92
2014-01-01 to 2014-12-3123,677,366USD365
2014-07-01 to 2014-09-304,007USD92
2014-04-01 to 2014-06-307,968USD91
2014-01-01 to 2014-03-317,501USD90
2013-10-01 to 2013-12-316,704USD92
2013-01-01 to 2013-12-3125,313,731USD365
2013-07-01 to 2013-09-306,143USD92
2013-04-01 to 2013-06-306,211USD91
2013-01-01 to 2013-03-316,256USD90
2012-01-01 to 2012-12-3115,054,369USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-12-31857,055USD365
2013-01-01 to 2013-12-31674,725USD365
2012-01-01 to 2012-12-31358,367USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-58USD92
2014-01-01 to 2014-12-31-144,698USD365
2014-07-01 to 2014-09-30-58USD92
2014-04-01 to 2014-06-30-22USD91
2014-01-01 to 2014-03-31-7USD90
2013-10-01 to 2013-12-31-28USD92
2013-01-01 to 2013-12-31-153,702USD365
2013-07-01 to 2013-09-30-108USD92
2013-04-01 to 2013-06-30-18USD91
2013-01-01 to 2013-03-310USD90
2012-01-01 to 2012-12-31-947,834USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-03-25 to 2014-04-02101,900,000USD9

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-5,490,605USD365
2013-01-01 to 2013-12-312,508,687USD365
2012-01-01 to 2012-12-311,409,738USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-3,700,175USD365
2013-01-01 to 2013-12-31-386,241USD365
2012-01-01 to 2012-12-31524,936USD366

Inspect the source

Entity
ENDOCYTE INC / CIK 0001235007
Captured
SEC response SHA-256
fa7da76c073b3895ba6769212bf598e872bbf5f159d8c19a8ae123614d925339

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001235007.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))